prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, carcinoma, infiltrating duct mixed wl other types. DEPARTMENT OF PATHOLOCY. SURCICAL PATHOLOCY REPORT. Material. mitted: Lef breast mass. Clinical. History: Clinical. Diagnosis: Operating. Cross Framination: A.) "Left breast mass". Tissue sent for ER/PR. In formalin. A single irregular piece. of Simm yellow and tan lobulated fibroadipose tissue which has been previously inked and. partially cross sectioned measuring 3.0 x 3.2 x 2.4 em. On cut surface there is a poorly. circumseribed firm gritty yellow-tan mass measuring approximately 2.7 x 2.4 x 1.8 cm. in greatest dimensions. This mass grossly extends to within the surgical margins. Sertally cross sectioned submitted in toto in Blocks 1 through. 7. MOROSCOPIC: The predor: mant component of the tumor is an infiltrating ductal. carettoma with almost no tubule formation. Extensive necrosis is seen in the. component. A mino: component of comedo type intraductal carcinoma is seen. a: the periphery, making up .ess than a quarter of the tumor. Scattered through the tumor. multiple foei of sarcomatous metaplasia characterized by myxoid stroma of high. with rudimentary cartilaginous differentiation. Although small foci of this. metaCiasta are seattered through the tumor, the epitheliat component of the tumor. predominates. Tumor extends to the margin of resection. The adjacent breast shows duet. ectusia and papillary apocrine metaplasia. DIAGNOSIS: "LEFT BREAST MASS": COMEDO INTRADUCTAL AND INFILTRATING. DUCTAL CARCINOMA NUCLEAR GRADE POORLY. DIFFERENTIATED, HISTOLOGIC GRADE 3 OF 3 (2.7 CM. IN. GREATEST DIAMETER), EXTENDING TO THE SURGICAL MARGIN. SARCOMATOUS METAPLASIA IS SEEN. SEE COMMENT. COMMENT: This reviewed. concurs.

expanded version (tokens=879) : 
 Based on the breast pathology report, the following information can be extracted:

1. Histological classification: The tumor is categorized as Basal subtype carcinoma, infiltrating duct mixed with other types, specifically comedo intraductal and infiltrating ductal carcinoma. 

2. Subtype: Basal subtype carcinoma 

3. Necrosis: The report mentions extensive necrosis seen in the tumor component. 

4. Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.

5. Histological grade: The tumor is classified as poorly differentiated with a histologic grade of 3 out of 3.

6. Nuclear grade: The nuclear grade of the carcinoma is also mentioned as poorly differentiated.

7. Lymphovascular invasion: There is no mention of lymphovascular invasion.

8. Calcification: There is no mention of calcification.

9. Receptor status: Tissue was sent for estrogen and progesterone receptor testing (ER/PR). The report does not mention the results of the test.

10. IHC and ancillary testing: There is no mention of any IHC or ancillary testing in the report.

Overall, the report describes a 2.7 cm poorly differentiated, basal subtype carcinoma, infiltrating duct mixed with other types, predominantly composed of infiltrating ductal carcinoma and containing scattered foci of sarcomatous metaplasia. The tumor is associated with extensive necrosis and is found to extend

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1008) : 
 Breast pathology report describes a 2.7 cm poorly differentiated basal subtype carcinoma with extensive necrosis and scattered foci of sarcomatous metaplasia. The tumor is composed of comedo intraductal and infiltrating ductal carcinoma, extending to the surgical margin. No mention of lymphovascular invasion or calcification found. ER/PR receptor status not included in the report.

